activin A receptor, type IIA | |
---|---|
Identifiers | |
Symbol | ACVR2A |
Alt. symbols | ACVR2 |
Entrez | 92 |
HUGO | 173 |
OMIM | 102581 |
RefSeq | NM_001616 |
UniProt | P27037 |
Other data | |
Locus | Chr. 2 q22.2-23.3 |
activin A receptor, type IIB | |
---|---|
Identifiers | |
Symbol | ACVR2B |
Entrez | 93 |
HUGO | 174 |
OMIM | 602730 |
RefSeq | NM_001106 |
UniProt | Q13705 |
Other data | |
Locus | Chr. 3 p22 |
The Activin type 2 receptors modulate signals for ligands belonging to the Transforming growth factor beta superfamily of ligands. These include: Activin (or Inhibin), Bone morphogenetic proteins and Nodal. They are involved in a host of physiological processes including, growth, cell differentiation, homeostasis, osteogenesis, apoptosis and many other functions. There are two Activin type two receptors: ACVR2A and ACVR2B.
Despite the large amount of processes that these ligands regulate, they all operate through essentially the same pathway: A ligand binds to a Type two receptor, which recruits and trans-phosphorylates a type I receptor. The type I receptor recruits a receptor regulated SMAD (R-SMAD) which it phosphorylates. The RSMAD then translocates to the nucleus where it functions as a transcription factor.
Several ligands that signal through the Activin type II receptors regulate muscle growth.Myostatin, a TGF-beta superfamily member, is a negative regulator of muscle growth. Myostatin binds to ACVR2B and to a lesser extent ACVR2A. In mice that were ACVR2A −/− (null) mutants there was an increase in all four muscle groups studied (, triceps, quadriceps, and gastrocnemious/plantaris muscles). Two of these muscle groups ( and triceps) were increased in ACVR2B −/− (null) mutants.